• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在正常人体中进行个体尿蛋白质组分析,以确定代表正常尿蛋白质组的最小样本数量。

An individual urinary proteome analysis in normal human beings to define the minimal sample number to represent the normal urinary proteome.

机构信息

Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifuyan, Wangfujing Street, Beijing, China.

Department of Physiology and Pathophysiology, National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences/School of Basic Medicine Peking Union Medical College, 5 Dong Dan San Tiao, Beijing, China.

出版信息

Proteome Sci. 2012 Nov 21;10(1):70. doi: 10.1186/1477-5956-10-70.

DOI:10.1186/1477-5956-10-70
PMID:23170922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3544588/
Abstract

BACKGROUND

The urinary proteome has been widely used for biomarker discovery. A urinary proteome database from normal humans can provide a background for discovery proteomics and candidate proteins/peptides for targeted proteomics. Therefore, it is necessary to define the minimum number of individuals required for sampling to represent the normal urinary proteome.

METHODS

In this study, inter-individual and inter-gender variations of urinary proteome were taken into consideration to achieve a representative database. An individual analysis was performed on overnight urine samples from 20 normal volunteers (10 males and 10 females) by 1DLC/MS/MS. To obtain a representative result of each sample, a replicate 1DLCMS/MS analysis was performed. The minimal sample number was estimated by statistical analysis.

RESULTS

For qualitative analysis, less than 5% of new proteins/peptides were identified in a male/female normal group by adding a new sample when the sample number exceeded nine. In addition, in a normal group, the percentage of newly identified proteins/peptides was less than 5% upon adding a new sample when the sample number reached 10. Furthermore, a statistical analysis indicated that urinary proteomes from normal males and females showed different patterns. For quantitative analysis, the variation of protein abundance was defined by spectrum count and western blotting methods. And then the minimal sample number for quantitative proteomic analysis was identified.

CONCLUSIONS

For qualitative analysis, when considering the inter-individual and inter-gender variations, the minimum sample number is 10 and requires a balanced number of males and females in order to obtain a representative normal human urinary proteome. For quantitative analysis, the minimal sample number is much greater than that for qualitative analysis and depends on the experimental methods used for quantification.

摘要

背景

尿蛋白质组已被广泛用于生物标志物的发现。正常人群的尿蛋白质组数据库可以为发现蛋白质组学提供背景,并为靶向蛋白质组学提供候选蛋白质/肽。因此,有必要定义取样所需的最少个体数量,以代表正常尿蛋白质组。

方法

在这项研究中,考虑到个体间和性别间的尿蛋白质组差异,以实现具有代表性的数据库。对 20 名正常志愿者(10 名男性和 10 名女性)的过夜尿液样本进行个体分析,采用 1DLC/MS/MS。为了获得每个样本的代表性结果,对其进行了重复的 1DLC-MS/MS 分析。通过统计分析估计最小样本数。

结果

定性分析中,当样本数超过 9 时,男性/女性正常组中通过添加新样本,新鉴定的蛋白质/肽不到 5%。此外,在正常组中,当样本数达到 10 时,通过添加新样本,新鉴定的蛋白质/肽不到 5%。此外,统计分析表明,正常男性和女性的尿蛋白质组显示出不同的模式。定量分析中,通过光谱计数和 Western blot 方法定义蛋白质丰度的变化。然后确定了定量蛋白质组学分析的最小样本数。

结论

定性分析时,考虑到个体间和性别间的差异,最小样本数为 10,并且需要平衡的男性和女性数量,以获得具有代表性的正常人类尿蛋白质组。定量分析时,最小样本数比定性分析多得多,并且取决于用于定量的实验方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/f9545ae881db/1477-5956-10-70-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/559de48fc2d5/1477-5956-10-70-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/2344dd2e4b57/1477-5956-10-70-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/206bf5ac30cb/1477-5956-10-70-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/b26f1e20cefc/1477-5956-10-70-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/57e7402ae1de/1477-5956-10-70-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/4478e107abfc/1477-5956-10-70-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/f9545ae881db/1477-5956-10-70-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/559de48fc2d5/1477-5956-10-70-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/2344dd2e4b57/1477-5956-10-70-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/206bf5ac30cb/1477-5956-10-70-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/b26f1e20cefc/1477-5956-10-70-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/57e7402ae1de/1477-5956-10-70-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/4478e107abfc/1477-5956-10-70-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb85/3544588/f9545ae881db/1477-5956-10-70-7.jpg

相似文献

1
An individual urinary proteome analysis in normal human beings to define the minimal sample number to represent the normal urinary proteome.在正常人体中进行个体尿蛋白质组分析,以确定代表正常尿蛋白质组的最小样本数量。
Proteome Sci. 2012 Nov 21;10(1):70. doi: 10.1186/1477-5956-10-70.
2
A Proteomic Analysis of Individual and Gender Variations in Normal Human Urine and Cerebrospinal Fluid Using iTRAQ Quantification.使用iTRAQ定量技术对正常人类尿液和脑脊液中的个体及性别差异进行蛋白质组学分析。
PLoS One. 2015 Jul 29;10(7):e0133270. doi: 10.1371/journal.pone.0133270. eCollection 2015.
3
A comprehensive profile and inter-individual variations analysis of the human normal amniotic fluid proteome.全面分析人类正常羊水蛋白质组的图谱和个体间差异。
J Proteomics. 2019 Feb 10;192:1-9. doi: 10.1016/j.jprot.2018.04.023. Epub 2018 Apr 22.
4
Dynamic urinary proteomic analysis reveals stable proteins to be potential biomarkers.动态尿蛋白质组学分析显示稳定蛋白可能成为潜在的生物标志物。
Proteomics Clin Appl. 2009 Mar;3(3):370-82. doi: 10.1002/prca.200800061.
5
Proteomic analysis of individual variation in normal livers of human beings using difference gel electrophoresis.使用差异凝胶电泳对人类正常肝脏个体差异进行蛋白质组学分析。
Proteomics. 2006 Oct;6(19):5260-8. doi: 10.1002/pmic.200600006.
6
Regional Differences of the Urinary Proteomes in Healthy Chinese Individuals.健康中国人群尿液蛋白质组的区域差异
Chin Med Sci J. 2019 Sep 30;34(3):157-167. doi: 10.24920/003504.
7
Evaluation of Urinary Proteome Library Generation Methods on Data-Independent Acquisition MS Analysis and its Application in Normal Urinary Proteome Analysis.尿液蛋白质组库生成方法在数据非依赖采集质谱分析中的评估及其在正常尿液蛋白质组分析中的应用
Proteomics Clin Appl. 2019 Sep;13(5):e1800152. doi: 10.1002/prca.201800152. Epub 2019 May 2.
8
96DRA-Urine: A high throughput sample preparation method for urinary proteome analysis.96DRA-Urine:一种用于尿液蛋白质组分析的高通量样品制备方法。
J Proteomics. 2022 Apr 15;257:104529. doi: 10.1016/j.jprot.2022.104529. Epub 2022 Feb 16.
9
Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome.正常尿蛋白质组内个体间和个体内变异性的定量分析。
J Proteome Res. 2011 Feb 4;10(2):637-45. doi: 10.1021/pr100835s. Epub 2011 Jan 5.
10
Practical points in urinary proteomics.尿液蛋白质组学的实用要点。
J Proteome Res. 2007 Oct;6(10):3881-90. doi: 10.1021/pr070328s. Epub 2007 Sep 7.

引用本文的文献

1
Urinary Collectrin (TMEM27) as Novel Marker for Acute Kidney Injury.尿收集素(TMEM27)作为急性肾损伤的新型标志物。
Life (Basel). 2022 Sep 6;12(9):1391. doi: 10.3390/life12091391.
2
HBFP: a new repository for human body fluid proteome.HBFP:人体体液蛋白质组学的新资源库。
Database (Oxford). 2021 Oct 13;2021. doi: 10.1093/database/baab065.
3
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease.尿载脂蛋白C3是阿尔茨海默病的潜在生物标志物。

本文引用的文献

1
Dynamic urinary proteomic analysis reveals stable proteins to be potential biomarkers.动态尿蛋白质组学分析显示稳定蛋白可能成为潜在的生物标志物。
Proteomics Clin Appl. 2009 Mar;3(3):370-82. doi: 10.1002/prca.200800061.
2
An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database.一种将肽的串联质谱数据与蛋白质数据库中氨基酸序列相关联的方法。
J Am Soc Mass Spectrom. 1994 Nov;5(11):976-89. doi: 10.1016/1044-0305(94)80016-2.
3
Analysis of the variability of human normal urine by 2D-GE reveals a "public" and a "private" proteome.
Dement Geriatr Cogn Dis Extra. 2020 Sep 11;10(3):94-104. doi: 10.1159/000509561. eCollection 2020 Sep-Dec.
4
Human body-fluid proteome: quantitative profiling and computational prediction.人体体液蛋白质组:定量分析和计算预测。
Brief Bioinform. 2021 Jan 18;22(1):315-333. doi: 10.1093/bib/bbz160.
5
Structural analysis of urinary light chains and proteomic analysis of hyaline tubular casts in light chain associated kidney disorders.轻链相关性肾脏疾病中尿轻链的结构分析及透明管型的蛋白质组学分析
PeerJ. 2019 Oct 2;7:e7819. doi: 10.7717/peerj.7819. eCollection 2019.
6
Comprehensive Analysis of Individual Variation in the Urinary Proteome Revealed Significant Gender Differences.全面分析尿液蛋白质组中的个体差异揭示了显著的性别差异。
Mol Cell Proteomics. 2019 Jun;18(6):1110-1122. doi: 10.1074/mcp.RA119.001343. Epub 2019 Mar 20.
7
More complete polarization of renal tubular epithelial cells by artificial urine.人工尿液使肾小管上皮细胞极化更完全。
Cell Death Discov. 2018 Oct 10;4:47. doi: 10.1038/s41420-018-0112-z. eCollection 2018.
8
Male kidney allograft recipients at risk for urinary tract infection?男性肾移植受者有发生尿路感染的风险吗?
PLoS One. 2017 Nov 16;12(11):e0188262. doi: 10.1371/journal.pone.0188262. eCollection 2017.
9
Effect of Sweetened Dried Cranberry Consumption on Urinary Proteome and Fecal Microbiome in Healthy Human Subjects.甜蔓越莓干摄入对健康人体尿液蛋白质组和粪便微生物组的影响。
OMICS. 2018 Feb;22(2):145-153. doi: 10.1089/omi.2016.0167. Epub 2017 Jun 15.
10
Urinary neprilysin in the critically ill patient.危重症患者的尿中性肽链内切酶
BMC Nephrol. 2017 May 25;18(1):172. doi: 10.1186/s12882-017-0587-5.
二维凝胶电泳分析人正常尿液的可变性揭示了“公共”和“私人”蛋白质组。
J Proteomics. 2011 Dec 10;75(1):70-80. doi: 10.1016/j.jprot.2011.06.031. Epub 2011 Jul 20.
4
A comprehensive map of the human urinary proteome.人类尿蛋白质组全景图。
J Proteome Res. 2011 Jun 3;10(6):2734-43. doi: 10.1021/pr2003038. Epub 2011 May 9.
5
Urine proteomics for profiling of human disease using high accuracy mass spectrometry.使用高精度质谱法进行尿液蛋白质组学分析以研究人类疾病
Proteomics Clin Appl. 2009 Sep 1;3(9):1052-1061. doi: 10.1002/prca.200900008.
6
Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome.正常尿蛋白质组内个体间和个体内变异性的定量分析。
J Proteome Res. 2011 Feb 4;10(2):637-45. doi: 10.1021/pr100835s. Epub 2011 Jan 5.
7
Challenges and opportunities for discovery of disease biomarkers using urine proteomics.利用尿液蛋白质组学发现疾病生物标志物面临的挑战与机遇
Pediatr Int. 2011 Feb;53(1):1-6. doi: 10.1111/j.1442-200X.2010.03253.x.
8
Discovery and validation of urinary biomarkers for prostate cancer.前列腺癌尿液生物标志物的发现与验证
Proteomics Clin Appl. 2008 Mar 7;2(4):556-570. doi: 10.1002/prca.200780082.
9
The consequences of sample pooling in proteomics: an empirical study.蛋白质组学中样本合并的后果:一项实证研究。
Electrophoresis. 2009 Sep;30(17):2967-2975. doi: 10.1002/elps.200900210.
10
Investigating sample pooling strategies for DIGE experiments to address biological variability.研究用于差异凝胶电泳(DIGE)实验的样本合并策略,以应对生物变异性。
Proteomics. 2009 Jan;9(2):388-97. doi: 10.1002/pmic.200800485.